Holds 2 active US DMFs for teriparatide, filing since 2019. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds 2 active US DMFs for teriparatide, filing since 2019. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for teriparatide, filing since 2019. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF for teriparatide, filing since 2019. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for teriparatide, filing since 2025.
Holds one active US DMF for teriparatide, filing since 2025.
This page filters the worldwide Teriparatide manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free